Guardant | search
Click here to view Guardant news from 60+ newspapers.
Bookmark or Share- FDA Approves Blood Tests That Can Help Guide Cancer TreatmentThe Food and Drug Administration (FDA) has approved two blood tests, known as liquid biopsies, that can help guide treatment decisions for people with cancer. The tests, Guardant360 CDx and FoundationOne Liquid CDx, are made by different companies and were approved separately. Doctors have traditionally based treatment decisions on features ...
- Home - Guardant HealthGuardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data. Our Shield™ blood test gains FDA approval, ushering in a new era of colorectal cancer screening.
- Guardant HealthSIGN IN. Forgot your password? New to Guardant? Register new account.
- Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong ...PALO ALTO, Calif., September 13, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data from ...
- Tests for Patients with Early and Advanced Stage Cancer - Guardant HealthMinimal Residual Disease Detection and Recurrence Monitoring. Guardant Reveal is a completely tissue-free test that detects circulating tumor DNA (ctDNA) for minimal residual disease (MRD) assessment in early-stage colorectal, breast, and lung cancers.
More
